Axa S.A. Celldex Therapeutics, Inc. Transaction History

Axa S.A.

$33.6 Billion
Q2 2025

A detailed history of Axa S.A. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Axa S.A. holds 185,100 shares of CLDX stock, worth $4.81 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

185,100

Previous 184,803 0.16%

Holding current value

$4.81 Million

Previous $3.35 Million 12.28%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$15.13 - $21.65 $4,493 - $6,430	297 Added 0.16%	185,100 $3.77 Million
Q1 2025 May 15, 2025	SELL	$18.15 - $27.6 $4,301 - $6,541	-237 Reduced 0.13%	184,803 $3.35 Million
Q4 2024 Feb 14, 2025	SELL	$23.31 - $32.4 $6,853 - $9,525	-294 Reduced 0.16%	185,040 $4.68 Million
Q3 2024 Nov 14, 2024	BUY	$32.06 - $44.56 $1.38 Million - $1.92 Million	43,044 Added 30.25%	185,334 $6.3 Million
Q2 2024 Feb 25, 2025	SELL	$32.76 - $42.56 $1.4 Million - $1.82 Million	-42,750 Reduced 23.1%	142,290 $5.27 Million
Q2 2024 Aug 14, 2024	BUY	$32.76 - $42.56 $2,653 - $3,447	81 Added 0.06%	142,290 $5.27 Million
Q1 2024 May 15, 2024	BUY	$35.22 - $51.88 $1,373 - $2,023	39 Added 0.03%	142,209 $5.97 Million
Q4 2023 Jul 16, 2024	SELL	$22.61 - $40.65 $881 - $1,585	-39 Reduced 0.03%	142,170 $5.64 Million
Q4 2023 Feb 14, 2024	SELL	$22.61 - $40.65 $77,755 - $139,795	-3,439 Reduced 2.36%	142,170 $5.64 Million
Q3 2023 Nov 14, 2023	BUY	$25.45 - $37.46 $801,140 - $1.18 Million	31,479 Added 27.58%	145,609 $4.01 Million
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $47,555 - $60,099	1,570 Added 1.39%	114,130 $3.87 Million
Q1 2023 May 15, 2023	SELL	$34.78 - $47.43 $9,008 - $12,284	-259 Reduced 0.23%	112,560 $4.05 Million
Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $1.29 Million - $2.11 Million	-46,400 Reduced 29.14%	112,819 $5.03 Million
Q3 2022 Feb 14, 2023	BUY	$22.7 - $37.57 $712,848 - $1.18 Million	31,403 Added 24.57%	159,219 $4.48 Million
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $712,848 - $1.18 Million	31,403 Added 24.57%	159,219 $4.48 Million
Q2 2022 Feb 14, 2023	SELL	$20.5 - $37.33 $555,693 - $1.01 Million	-27,107 Reduced 17.5%	127,816 $3.45 Million
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $555,693 - $1.01 Million	-27,107 Reduced 17.5%	127,816 $3.45 Million
Q1 2022 Feb 14, 2023	SELL	$27.64 - $39.32 $118,741 - $168,918	-4,296 Reduced 2.7%	154,923 $5.28 Million
Q1 2022 May 13, 2022	SELL	$27.64 - $39.32 $110,532 - $157,240	-3,999 Reduced 2.52%	154,923 $5.28 Million
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $144,896 - $228,512	-4,061 Reduced 2.49%	158,922 $6.14 Million
Q3 2021 Nov 15, 2021	SELL	$28.95 - $55.99 $1.91 Million - $3.69 Million	-65,968 Reduced 28.81%	162,983 $8.8 Million
Q2 2021 Aug 13, 2021	SELL	$20.71 - $35.37 $1.43 Million - $2.43 Million	-68,832 Reduced 23.11%	228,951 $7.66 Million
Q1 2021 May 14, 2021	BUY	$16.19 - $29.91 $4.65 Million - $8.59 Million	287,283 Added 2736.03%	297,783 $6.13 Million
Q4 2020 Feb 12, 2021	BUY	$14.99 - $22.75 $157,395 - $238,875	10,500 New	10,500 $184,000

Others Institutions Holding CLDX

# of Institutions

202

Shares Held

68.3M

Call Options Held

219K

Put Options Held

238K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account